Isabel Rodríguez Sánchez | Health Sciences | Best Researcher Award | 13387

Assoc Prof Dr. Isabel Rodríguez Sánchez | Health Sciences | Best Researcher Award 

Assoc Prof Dr. Isabel Rodríguez Sánchez, Clínico San Carlos University Hospital, Spain

Assoc. Prof. Dr. Isabel Rodríguez Sánchez is a specialist in Geriatrics at Clínico San Carlos University Hospital in Madrid, Spain. She holds a PhD in Epidemiology and Public Health and serves as an associate professor at the Complutense University of Madrid. Her research focuses on frailty, chronic disease, and functional impairment in older adults, with over 25 scientific publications, many in high-impact journals. Dr. Rodríguez Sánchez also contributes to national health policy as a member of the Spanish Agency for Medicines and Medical Devices.

Profile

Orcid

🎓 Early Academic Pursuits

Assoc. Prof. Dr. Isabel Rodríguez Sánchez began her academic journey with a strong foundation in medicine, graduating from the Universidad Complutense de Madrid in 2014. Her passion for improving the lives of older adults through evidence-based medical practice guided her specialization in Geriatrics, a field she pursued through rigorous training at the Hospital Universitario La Paz, one of Spain’s most reputable institutions for medical education. Her commitment to research and academic excellence was further solidified with the completion of a PhD in Epidemiology and Public Health from the Universidad Autónoma de Madrid in 2021. Her doctoral thesis, “Dolor crónico, deterioro funcional y enfermedad cardiovascular en las personas mayores,” earned the highest distinction: Cum Laude with an Extraordinary Doctorate Award.

🩺 Professional Endeavors

Dr. Rodríguez Sánchez has accumulated a wealth of clinical experience across several prestigious Spanish institutions. She began her medical career as a Médico Interno Residente (MIR) in Geriatrics from 2015 to 2019 at Hospital Universitario La Paz. This formative period laid the groundwork for her deep understanding of aging, frailty, and complex chronic conditions in older adults.

From 2019 to 2020, she worked as a Geriatrics Specialist at the Hospital de Navarra and concurrently served as a Clinical Associate Professor at the University of Navarra, mentoring young medical students in geriatric medicine. Since 2020, she has held the position of Facultativo Especialista de Área (Consultant Geriatrician) at the Hospital Clínico San Carlos in Madrid, one of Spain’s leading academic hospitals.

In addition to her clinical roles, she was appointed as a Member of the Committee for the Safety of Medicines for Human Use at the Spanish Agency of Medicines and Medical Devices (AEMPS) in 2024, demonstrating her engagement with national health governance and patient safety.

🔬 Contributions and Research Focus

Dr. Rodríguez Sánchez’s research has made significant contributions to the field of aging, particularly in the study of frailty, sarcopenia, chronic diseases, and functional impairment. She has authored or co-authored 25 scientific publications, with 13 published in top-tier Q1 journals, and accumulated over 1300 citations.

Her most notable work includes studies on functional decline following COVID-19 hospitalization in the elderly, multimorbidity in older adults, and the integration of technology for assessing pain and sarcopenia. She is also a co-author of seven book chapters, both in Spanish and international publications, further solidifying her expertise in Geriatrics.

Her research is interdisciplinary, often incorporating biomarkers, imaging (e.g., ultrasound for muscle mass), and digital health tools to enhance diagnosis, prevention, and treatment of geriatric syndromes.

🏅 Accolades and Recognition

Dr. Rodríguez Sánchez has earned numerous awards and recognitions that underscore her contributions to geriatric medicine. In 2022, she received the “Best Abstract – ECGI Category (Early-Career Geriatricians Initiative) Stefania Maggi Award” at the European Geriatric Medicine Society Congress in London. Her award-winning study focused on functional impairment in individuals aged 80+ following COVID-19 hospitalization—a prospective study that she both designed and led.

She has also been invited to serve as a peer reviewer for high-impact international journals, such as Aging Research Reviews, Frontiers, Environmental Research, and the Journal of the American Medical Directors Association, reflecting her respected position in the global research community.

🌍 Impact and Influence

Beyond her publications, Dr. Rodríguez Sánchez actively influences healthcare practice and policy through project evaluations for national and international research funding bodies. Her involvement ensures that projects related to frailty, sarcopenia, post-stroke balance evaluation, and chronic pain management using technological solutions are rigorously assessed and guided by clinical relevance and scientific rigor.

Her dual roles in both clinical practice and academic teaching—as a professor at the Complutense University of Madrid since 2022—enable her to shape the next generation of healthcare professionals. She teaches across multiple programs, including Medicine, Nutrition, and the Master’s in Nutrigenetics, promoting an integrated approach to geriatric care.

🌟 Legacy and Future Contributions

Assoc. Prof. Dr. Isabel Rodríguez Sánchez stands out as a dynamic physician-researcher whose work bridges the gap between science, clinical care, and policy. Her dedication to improving health outcomes for older adults, especially the most vulnerable, positions her as a future leader in geriatric innovation.

Looking forward, she is expected to continue advancing multidimensional assessment tools, precision interventions for frailty and sarcopenia, and policy-oriented research that influences national and European standards of care for the elderly.

Her legacy is being built not only on her academic achievements and clinical expertise but also on her role as a mentor, educator, and advocate for dignified and effective aging care. 🌱

Publication Top Notes

ContributorsIsabel Rodriguez; Jose Antonio Carnicero; Alejandro Álvarez-Bustos; Francisco José García-García; Leocadio Rodríguez-Mañas; Helio
Coelho-Junior
Journal: Nutrients
Year: 2025

Research on Frailty: Where We Stand and Where We Need to Go

ContributorsRodríguez-Mañas, L.; Rodriguez-Sánchez, I.
Journal: American Medical Directors Association
Year: 2021
ContributorsBani Hassan, E.; Phu, S.; Vogrin, S.; Escobedo Terrones, G.; Pérez, X.; Rodriguez-Sanchez, I.; Duque, G.
Journal: Calcified Tissue International
Year: 2019

 

 

Wenjian Mao | Health Sciences | Best Researcher Award | 13235

Mr. Wenjian Mao | Health Sciences | Best Researcher Award

Mr. Wenjian Mao, Jinling Hospital, Nanjing University, China

Mr. Wenjian Mao is a postdoctoral researcher at the Department of Critical Care Medicine, Nanjing University, China. He holds a Medical Doctor degree from Nanjing Medical University and specializes in the diagnosis and treatment of acute pancreatitis, with a focus on clinical and experimental research. His academic contributions include multiple publications in prestigious journals, covering topics such as infected pancreatic necrosis, systemic anticoagulation, immune dysfunction, and kidney complications in acute pancreatitis. He is affiliated with Jinling Hospital, Nanjing University.

Profile

Orcid

Scopus

Early Academic Pursuits 🎓

Wenjian Mao embarked on his academic journey in medicine with a strong foundation at Guangzhou Medical University, where he earned his Bachelor of Medicine degree between 2011 and 2016. During this time, he developed a keen interest in medical sciences, particularly in the field of critical care and acute conditions. Building upon this foundation, he pursued a Master of Medicine at Southern Medical University from 2016 to 2019. His academic pursuits were characterized by a rigorous exploration of clinical medicine, setting the stage for his specialization in acute pancreatitis. His passion for advancing medical knowledge and patient care led him to enroll in the Medical Doctor program at Nanjing Medical University, where he further honed his expertise from 2019 to 2022. This progression through highly regarded medical institutions equipped him with a strong clinical and research background that would later define his professional contributions.

Professional Endeavors 🏥

Following his extensive education, Wenjian Mao took on the role of a postdoctoral researcher at Nanjing University’s Department of Critical Care Medicine. His professional experience is deeply rooted in the diagnosis and treatment of acute pancreatitis, a condition that presents significant challenges in critical care settings. His clinical practice at Jinling Hospital, affiliated with Nanjing University, has been instrumental in shaping his understanding of the disease’s complexities. He is actively engaged in both clinical and experimental research, striving to develop innovative approaches to the management and treatment of acute pancreatitis. His expertise encompasses patient assessment, therapeutic interventions, and longitudinal studies aimed at improving clinical outcomes. His work not only benefits individual patients but also contributes to the broader medical community’s understanding of acute pancreatitis management.

Contributions and Research Focus 📚

Wenjian Mao’s research is primarily focused on acute pancreatitis, with an emphasis on early detection, management, and patient outcomes. His scholarly contributions include a range of peer-reviewed publications that address critical aspects of pancreatitis treatment. His study on the prediction of infected pancreatic necrosis using the modified pancreatitis activity scoring system provides valuable insights into early intervention strategies. Additionally, his research on systemic anticoagulation in acute necrotizing pancreatitis patients has shed light on reducing hospital readmissions, improving patient recovery, and minimizing complications.

Other notable studies include his exploration of immune function in severe pancreatitis cases, where he was involved in a multicenter, double-blind, randomized controlled trial focusing on immune enhancement therapy. His work in identifying key biomarkers, such as mean absolute lymphocyte count as a predictor of infected pancreatic necrosis, further underscores his commitment to advancing diagnostic precision in the field. Moreover, his investigation into autoantibodies as independent risk factors for hypertriglyceridemia-induced pancreatitis recurrence highlights his innovative approach to understanding disease mechanisms. These contributions collectively enhance the medical community’s ability to diagnose, treat, and manage acute pancreatitis more effectively.

Accolades and Recognition 🏆

As a result of his groundbreaking work, Wenjian Mao has gained recognition in the medical research community. His studies have been published in reputable journals such as United European Gastroenterology Journal, Hepatobiliary Pancreatic Diseases International, Intensive Care Medicine, and the Journal of Clinical Lipidology. His findings have contributed to a growing body of literature that informs best practices in critical care and gastroenterology. Additionally, his collaborative efforts with other leading researchers have led to impactful studies on sepsis-related immune dysfunction and major adverse kidney events in pancreatitis patients. These accomplishments reflect his dedication to scientific excellence and his ongoing commitment to improving patient care.

Publication Top Notes

Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort study

Contributors: Xiang Luo; Xiaoling Li; Xiaoyan Lai; Wenjian Mao; Lu Ke; Lingyan Fu; Lin Gao; Yaolu Liu
Journal: BMJ Open Gastroenterology
Year: 2025
ContributorsXiaofei Huang; Wenjian Mao; Xingxing Hu; Fengxia Qin; Hui Zhao; Aiping Zhang; Xinyu Wang; Christian Stoppe; Dandan Zhou; Lu Ke et al.
Journal: Gut and Liver
Year: 2024

The Diagnosis and Treatment of Local Complications of Acute Necrotizing Pancreatitis in China: A National Survey

Contributors: Xiaowu Dong; Wenjian Mao; Lu Ke; Lin Gao; Jing Zhou; Bo Ye; Gang Li; Anthony Phillips; Zhihui Tong; John Windsor et al.
Journal: Gastroenterology Research and Practice
Year: 2021

Li-Na Gao | Pharmacology | Best Researcher Award | 13230

Assoc. Prof. Dr. Li-Na Gao | Pharmacology | Best Researcher Award 

Assoc. Prof. Dr. Li-Na Gao, Jining Medical University, China

Assoc. Prof. Dr. Li-Na Gao is a postdoctoral fellow at the University of British Columbia and an academic leader at Jining Medical University, China. Her research focuses on neuropsychopharmacology and anti-inflammatory immune pharmacology of traditional Chinese medicine (TCM). She has led multiple research projects, published over 40 academic papers (H-index: 21, citations: 1,900+), and collaborates on innovative TCM drug development. Dr. Gao holds key editorial and professional memberships, contributing significantly to TCM research, particularly in cardiovascular and cerebrovascular diseases, inflammation, and gut-brain interaction. She has secured ¥1.04 million in research funding and actively promotes TCM modernization.

Profile

Scopus

Early Academic Pursuits 🎓

Dr. Li-Na Gao embarked on her academic journey with a strong foundation in Traditional Chinese Medicine (TCM), leading her to become an esteemed researcher and educator in the field. Her passion for TCM and its applications in modern pharmacology inspired her to pursue advanced studies. After earning her Ph.D., she further honed her expertise as a postdoctoral fellow at the University of British Columbia. Her early academic years were marked by rigorous research into the pharmacological mechanisms of TCM, setting the stage for her later contributions to neuropsychopharmacology and inflammatory immune pharmacology.

Professional Endeavors 💼

Currently serving as an Associate Professor at Jining Medical University, Dr. Gao plays a crucial role in advancing the field of TCM. She has established herself as an academic leader in key TCM disciplines in Shandong Province. With her extensive background, she has been instrumental in mentoring students, conducting cutting-edge research, and collaborating with renowned institutions. Her work extends beyond academia, encompassing consultancy projects and significant contributions to the development of TCM-based treatments.

Contributions and Research Focus 📝

Dr. Gao’s research is primarily centered on the neuropsychopharmacology and inflammatory immune pharmacology of TCM. She has made significant contributions in the following areas:

  • Heart, Brain, and Intestine Disease Correlation: She has explored the scientific underpinnings of TCM theories, such as “the heart dominates the mind, and the small intestine is exterior to interior.”
  • Inflammatory Metabolic Damage and Depression: She has pioneered the understanding that inflammatory metabolic damage is a key pathological mechanism of depression and its co-occurrence with somatic diseases.
  • Intestinal-Brain Communication: Her work has identified TLR4 as the critical “bridge molecule” in mediating inflammatory metabolic disorders, enhancing our understanding of gut-brain interactions.
  • Secondary Development of TCM: She has provided significant insights into the mechanisms of Gegen Qinlian decoction, Scrophularia ningpoensis Hemsl., puerarin, and glycyrrhizic acid, thereby enhancing their applications in modern medicine.

Accolades and Recognition 🏆

Dr. Gao has been recognized for her outstanding contributions to research and academia. She has published over 40 academic papers, boasting an H-index of 21 and more than 1,900 citations. Her editorial appointments include:

  • Visiting Deputy Editor-in-Chief of Frontiers in Pharmacology (2021–Present)
  • Youth Editorial Board Member of Acupuncture and Herb Medicine (2022–2024)
  • Youth Editorial Board Member of Advanced Gut & Microbiome Research (2022–2023)
  • Youth Editorial Board Member of Tianjin Traditional Chinese Medicine (2023–Present)

She has also been an integral part of major collaborative research projects, including a 1.04 million RMB-funded project on acute and chronic inflammatory diseases in cooperation with Rizhao Hospital of Traditional Chinese Medicine.

Impact and Influence 🌍

Dr. Gao’s research has had a profound impact on the global TCM community. Her contributions extend beyond research papers and patents to shaping policies and educational curriculums. As a standing committee member of multiple prestigious organizations, she has influenced the standardization and modernization of TCM research. Her work in bridging the gap between traditional medicine and modern pharmacology has helped in integrating TCM into contemporary medical practices.

Publication Top Notes

Author: Xu, D., Gao, L.-N., Song, X.-J., Cui, Y.-L., Wang, Q.

Journal: Nanobiotechnology

Year: 2023

Author: Huang, M., He, Y., Tian, L., Gao, S., Yu, C.

Journal: Affective Disorders

Year: 2023

Polysaccharides from Scrophularia ningpoensis Hemsl. improve reserpine-induced depression-like behavior by inhibiting HTR2A/HTR2C mediated AKT/GSK3β/β-catenin/CBP/BDNF signalling

Author: Ruhui Shen, Jian’an Wang, Yijin Zhao, Zhaojin Dang , Ke Zhang, Ming Li , Qian Yang , Li-Na Gao

Journal: Biological Molecules

Year: 2025